Zoom Announces Termination of Merger Agreement with Five9

SAN JOSE, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced that Zoom and Five9 have mutually terminated the merger agreement executed by the parties on July 16, 2021. At Five9’s special meeting of stockholders held on September 30, 2021, Five9 did not obtain […] Lire la suite »

Merus Announces Poster Presentations on Zenocutuzumab and MCLA-158 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of the abstract titles and authors for two posters that will be […] Lire la suite »

Bike Share is Rapidly Taking the World by Storm Post-Covid

Montreal, Canada, Sept. 30, 2021 (GLOBE NEWSWIRE) — PBSC Urban Solutions expands across Spain, France & Romania with new systems PBSC has implemented more than 95 000 bikes and 7500 stations in 40+ cities for over a decade Europe’s post-covid focus on zero emissions target enforces the need for bike […] Lire la suite »

TJP Labs Announces Acquisition of Drug Establishment Licensed Facility from North American Ingredients

PICKERING, Ontario, Sept. 30, 2021 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced today that it has, through a wholly owned subsidiary, acquired certain assets of North American Ingredients Inc. (“NAI”), including NAI’s Drug Establishment and cGMP […] Lire la suite »

Looking Beyond DNA to See Cancer with New Clarity

SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) — Researchers at UC San Francisco and UC San Diego have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the way to identifying […] Lire la suite »

Rackspace Technology Announces Tech Industry Must Learn from its Past Cloud Talk Podcast Featuring Wyndham Hotel Group EVP and CIO Scott Strickland

SAN ANTONIO, Sept. 30, 2021 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, today announced a recent Solve ™ Cloud Talk podcast Rackspace Technology Announces Tech Industry Must Learn from its Past featuring Wyndham Hotel Group EVP and CIO Scott Strickland. The podcast covers […] Lire la suite »

Sloane Stephens joins MyXR Inc’s global team

LOS ANGELES, Sept. 30, 2021 (GLOBE NEWSWIRE) — Today, MyXR Inc, a global leader for SaaS XR and engagement software, announced the official addition of Sloane Stephens to its global team. Known as a fierce competitor as much as a positive, powerful force for the underrepresented, Sloane brings both her […] Lire la suite »

Virtusa Accelerates the Modernization and Personalization of Patient Care

SOUTHBOROUGH, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) — Virtusa Corporation, a global provider of digital strategy, digital engineering, and IT services and solutions, today announced vLife™ 6.0, a cloud-based marketplace designed to improve and personalize patient care. vLife™ 6.0 brings together previously inaccessible data with artificial intelligence (AI) applications, machine learning (ML) […] Lire la suite »

Fresche Solutions acquiert Abacus et devient le premier fournisseur au monde de solutions IBM i relatives à cloud, aux services gérés et à la modernisation d’applications

MONTRÉAL, 30 sept. 2021 (GLOBE NEWSWIRE) — Fresche Solutions est heureuse d’annoncer l’acquisition d’Abacus Solutions LLC, premier fournisseur de solutions relatives à cloud pour IBM i, aux services gérés et à l’infrastructure. Grâce à cette acquisition, Fresche devient le premier fournisseur au monde de solutions complètes relatives à IBM i ainsi que […] Lire la suite »

Fresche Solutions Acquires Abacus, Becomes the World’s First IBM i Cloud, Managed Services and Application Modernization Solution Provider

MONTREAL, Sept. 30, 2021 (GLOBE NEWSWIRE) — Fresche Solutions is pleased to announce the acquisition of Abacus Solutions LLC, a leading provider of IBM i cloud, managed services and infrastructure solutions. With this acquisition, Fresche becomes the world’s largest end-to-end provider of IBM i solutions and the premier modernization and […] Lire la suite »

Minerva Neurosciences Announces Study Results Demonstrating Bioequivalence of Phase 2b, Phase 3, and Planned Commercial Formulations of Roluperidone for Treatment of Negative Symptoms of Schizophrenia

WALTHAM, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced results from a pivotal bioequivalence study comparing the roluperidone formulations used in its late-stage Phase 2b and Phase 3 […] Lire la suite »

Despite Heightening Investor Pressure, Few Companies Publicly Report on Sustainability, Sphera’s New Survey Finds

CHICAGO, Sept. 30, 2021 (GLOBE NEWSWIRE) — Though pressure is growing from all corners—from investors, to governments, to boards of directors—companies worldwide struggle to report progress on their Environmental, Social and Governance (ESG) goals. Indeed, just 38% of businesses publicly communicate their sustainability performance, according to a new survey from […] Lire la suite »

Malgré une pression accrue des investisseurs, peu d’entreprises rendent leurs rapports sur le développement durable publics, selon la nouvelle enquête de Sphera

CHICAGO, 30 sept. 2021 (GLOBE NEWSWIRE) — Bien que la pression augmente de toutes parts, des investisseurs aux gouvernements en passant par les conseils d’administration, les entreprises du monde entier peinent à faire état de leurs progrès vers leurs objectifs environnementaux, sociaux et de gouvernance (ESG). En effet, seules 38 % […] Lire la suite »

Ergebnis einer neuen Umfrage von Sphera: trotz erhöhtem Investorendruck geben nur wenige Unternehmen öffentlich Auskunft über ihre Nachhaltigkeitsentwicklung

CHICAGO, Sept. 30, 2021 (GLOBE NEWSWIRE) — Obwohl der Druck von allen Seiten zunimmt – von Seiten der Investoren über Regierungen bis hin zu den Vorständen – fällt es Unternehmen weltweit schwer, Fortschritte bei ihren Zielen in den Bereichen Umwelt, Soziales und Unternehmensführung (ESG, Environmental, Social and Governance) zu vermelden. Laut einer […] Lire la suite »

Monument annonce ses résultats du quatrième trimestre et de l’exercice fiscal 2021

VANCOUVER, Colombie-Britannique, 30 sept. 2021 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V : MMY et FSE : D7Q1) (« Monument » ou la « Société ») a annoncé aujourd’hui ses résultats financiers annuels pour l’exercice clos au 30 juin 2021. Sauf indication contraire, tous les montants sont exprimés en dollars des États-Unis (USD) (consultez le site www.sedar.com pour […] Lire la suite »

Monument gibt Ergebnisse für das vierte Quartal und das Geschäftsjahr 2021 bekannt

VANCOUVER, British Columbia, Sept. 30, 2021 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY und FSE: D7Q1) „Monument“ bzw. das „Unternehmen“ hat heute die Jahresergebnisse für das am 30. Juni 2021 abgeschlossene Geschäftsjahr bekanntgegeben. Sofern keine anderen Angaben gemacht werden, verstehen sich sämtliche Beträge in US-Dollar (siehe www.sedar.com für alle Finanzergebnisse). President […] Lire la suite »

AIM ImmunoTech Announces Clinical Trial Agreement for a Phase 2a Human Challenge Trial of Ampligen as a Potential Intranasal Prophylaxis Against Respiratory Viruses

OCALA, Fla., Sept. 30, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American:AIM) today announced that AIM and hVIVO have a signed Clinical Trial Agreement (CTA) for a Phase 2a Human Challenge Trial (HCT) to test the company’s drug Ampligen as a potential intranasal prophylactic using a human rhinovirus (HRV-16, […] Lire la suite »

Phoenix Software apporte la première amélioration à la technologie JES3 en six ans avec JES3plus® V1R1

EL SEGUNDO, Californie, 30 sept. 2021 (GLOBE NEWSWIRE) — Phoenix Software International, Inc. a annoncé aujourd’hui la disponibilité générale de JES3plus V1R1, un produit dérivé basé sur z/OS® JES3 d’IBM. Cette version intègre les améliorations de performance d’E/S SPOOL mises à la disposition des clients JES3plus par le biais d’une livraison continue […] Lire la suite »

Phoenix Software bietet mit JES3plus® V1R1 erste Weiterentwicklung der JES3-Technologie seit sechs Jahren

EL SEGUNDO, Kalifornien, USA, Sept. 30, 2021 (GLOBE NEWSWIRE) — Phoenix Software International, Inc. hat heute die allgemeine Verfügbarkeit von JES3plus V1R1 bekanntgegeben, einem abgewandelten Produkt, das auf z/OS® JES3 von IBM basiert. Diese Version enthält die SPOOL E/A-Leistungsverbesserungen, die für JES3plus-Kunden bereits in den vergangenen Monaten durch kontinuierliche Bereitstellung zur Verfügung […] Lire la suite »